168 related articles for article (PubMed ID: 26330537)
1. 2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells.
Sobolewski C; Rhim J; Legrand N; Muller F; Cerella C; Mack F; Chateauvieux S; Kim JG; Yoon AY; Kim KW; Dicato M; Diederich M
J Pharmacol Exp Ther; 2015 Nov; 355(2):308-28. PubMed ID: 26330537
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
3. Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells.
Sobolewski C; Cerella C; Dicato M; Diederich M
Cell Cycle; 2011 Sep; 10(17):2978-93. PubMed ID: 21862873
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo.
Pyrko P; Soriano N; Kardosh A; Liu YT; Uddin J; Petasis NA; Hofman FM; Chen CS; Chen TC; Schönthal AH
Mol Cancer; 2006 May; 5():19. PubMed ID: 16707021
[TBL] [Abstract][Full Text] [Related]
6. COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.
Gallouet AS; Travert M; Bresson-Bepoldin L; Guilloton F; Pangault C; Caulet-Maugendre S; Lamy T; Tarte K; Guillaudeux T
Clin Cancer Res; 2014 May; 20(10):2663-73. PubMed ID: 24637636
[TBL] [Abstract][Full Text] [Related]
7. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
9. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells.
Chen C; Xu W; Wang CM
Leuk Lymphoma; 2013 Nov; 54(11):2517-22. PubMed ID: 23452119
[TBL] [Abstract][Full Text] [Related]
10. [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism].
Xie X; Li J; Wang RC; Geng RL; Wang SY; Wang C; Zhao XY; Hao HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):707-11. PubMed ID: 24989281
[TBL] [Abstract][Full Text] [Related]
11. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D
Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
13. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro.
Subhashini J; Mahipal SV; Reddanna P
Cancer Lett; 2005 Jun; 224(1):31-43. PubMed ID: 15911099
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress response as a possible mechanism of cyclooxygenase-2-independent anticancer effect of celecoxib.
Cha W; Park SW; Kwon TK; Hah JH; Sung MW
Anticancer Res; 2014 Apr; 34(4):1731-5. PubMed ID: 24692703
[TBL] [Abstract][Full Text] [Related]
16. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
17. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
18. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
19. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.
Katkoori VR; Manne K; Vital-Reyes VS; Rodríguez-Burford C; Shanmugam C; Sthanam M; Manne U; Chatla C; Abdulkadir SA; Grizzle WE
Biotech Histochem; 2013 Jan; 88(1):38-46. PubMed ID: 23167625
[TBL] [Abstract][Full Text] [Related]
20. Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma.
Abrahão AC; Giudice FS; Sperandio FF; Pinto Junior Ddos S
J Oral Pathol Med; 2013 Nov; 42(10):793-8. PubMed ID: 23679684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
